Elderly woman using a cane at home with daughter take care

Author: Michael Addelman

Source: Medical Xpress

Older people with mobility problems living without home adaptations have poorer health and higher levels of pain, according to researchers at The Universities of Manchester and Hong Kong.

The study of English data, published today in The Lancet Regional Health Europe also links the lack of adaptations to not being able to participate in social activities and having to move home within two years.

The analysis followed over 10,000 adults aged 60 and over living at home in England for an average of 11 years using data from the English Longitudinal Study of Aging.

The team compared older adults with and without mobility impairments living in homes that had been accommodated to their disability or that had remained unadjusted.

Among those with severe mobility impairments, home adaptions reduced the probability of falls by 3%, pain by 6%, and poor health by 4% compared to disabled adults coping without help.

Modifications for external access also increased the chances that people could go out of their home and participate in social life by 6% and the chances of them remaining in their homes for at least the next two years by 4%.

The adaptions they studied include widened doorways, access ramps, automatic doors, accessible parking, handrails and bathroom or kitchen modifications.

Lead author Honorary Professor Tarani Chandola from The University of Manchester said: “Mobility impairment is the most prevalent form of disability facing older adults today and includes difficulty in walking, climbing stairs, and getting up after sitting.

“But most of the housing stock in the UK is poorly designed for a rapidly aging population, with only 7% of homes in England in 2014 meeting the minimum standard of accessibility.

“Over 70% of older adults with a mobility impairment in England live in a home without an accommodation for their disability.”

Participants in the survey were asked if their homes had external modifications such as widened doorways, ramps, automatic doors, parking and a lift, and internal modifications such as rails, bathroom/kitchen modifications and a chair lift.

Mobility impairment was measured through reported difficulties in 10 activities including walking, climbing, getting up, reaching and lifting.

Five disability outcomes were analysed: falls in the previous two years, pain, poor self-rated health, no social activities, and moving home within next two years.

Until now, medical researchers often bundled up housing modifications with clinical or non-clinical interventions such as advice from a physiotherapist or exercise therapy, making it hard to separate the specific effect of home adaptations.

But thanks to the study, the team has been able to make a compelling case for additional investment in such home adaptations by policy makers.

He added: “Our study highlights how this topic has received little attention in debates about health and social care services.

“We now have strong and consistent evidence that housing adaptations can prevent a deterioration in the health, well-being, and quality of life of disabled older adults. That is why improving the quality of our housing is essential for achieving healthy aging in the community.”

More information

Tarani Chandola et al, Home modifications and disability outcomes: A longitudinal study of older adults living in England, The Lancet Regional Health — Europe (2022). DOI: 10.1016/j.lanepe.2022.100397 Provided by University of Manchester.

This article was from Medical Xpress and was legally licensed through the Industry Dive Content Marketplace. Please direct all licensing questions to legal​@industrydive.com.

Medical Xpress logo

Rate this content: 
Average: 2.7 (3 votes)
UK | June 2022 | 210771
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]